Perry David P's Form 4 filing
Better Therapeutics, Inc. (BTTX) · filed Nov 1, 2021
- Accession no.
- 0000899243-21-042250
- Filed
- Nov 1, 2021, 8:55 PM ET
- Trade date
- Apr 30-Oct 28, 2021
- Filing delay
- 185 daysLate
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 12 non-derivative transactions and 1 derivative transaction. Open-market purchases total $2.51M. It was filed 185 days after the trade, past the 2-business-day deadline.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Perry David PCIK 0001105941 | Director, Officer (See Remarks), 10% Owner |
| David P. Perry 2015 TrustCIK 0001890678 | 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2021 | Common Stock | PPurchaseAcquired | +2,000 | $9.95 | +$19,900 | 2,000 | Direct | |
| May 4, 2021 | Common Stock | PPurchaseAcquired | +3,476 | $9.93 | +$34,516.68 | 5,476 | Direct | |
| May 13, 2021 | Common Stock | PPurchaseAcquired | +7,000 | $9.93 | +$69,510 | 12,476 | Direct | |
| May 14, 2021 | Common Stock | PPurchaseAcquired | +3,060 | $9.93 | +$30,385.8 | 15,536 | Direct | |
| May 21, 2021 | Common Stock | PPurchaseAcquired | +8,000 | $9.95 | +$79,600 | 23,536 | Direct | |
| May 24, 2021 | Common Stock | PPurchaseAcquired | +8,000 | $9.94 | +$79,520 | 31,536 | Direct | |
| May 26, 2021 | Common Stock | PPurchaseAcquired | +20,000 | $9.95 | +$199,000 | 51,536 | Direct | |
| Oct 28, 2021 | Common Stock | AGrant or awardAcquired | +10,164,015 | – | – | 10,215,551 | Indirect | |
| Oct 28, 2021 | Common Stock | AGrant or awardAcquired | +293,150 | – | – | 10,508,701 | Indirect | |
| Oct 28, 2021 | Common Stock | AGrant or awardAcquired | +21,336 | – | – | 10,530,037 | Indirect | |
| Oct 28, 2021 | Common Stock | PPurchaseAcquired | +200,000 | $10.00 | +$2,000,000 | 10,730,037 | Indirect | |
| Oct 28, 2021 | Common Stock | AGrant or awardAcquired | +100,000 | $10.00 | +$1,000,000 | 10,830,037 | Indirect |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 28, 2021 | Common Stock | AGrant or awardAcquired | +28,300 | $0.00 | $0 | 28,300 | Direct | Duplicate filing |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.